SINOMED(SH:688108) Sou Hu Cai Jing·2025-08-07 17:54Trading Information Summary - Sino Medical (688108) closed at 17.03 yuan on August 7, 2025, with a 20.01% increase, reaching the daily limit [1] - The stock hit the limit at 9:25 AM and did not open the limit, with a closing order amount of 6.6132 million yuan, accounting for 0.09% of its market capitalization [1] - Net inflow of institutional funds was 28.9787 million yuan, representing 19.49% of total trading volume, while retail investors saw a net outflow of 8.2251 million yuan, accounting for 5.53% [1] Company Announcement Summary - Sino Medical's subsidiary, Sino Shenchang, received breakthrough medical device designation from the FDA for the COMETIU self-expanding intracranial drug-coated stent system and COMEX balloon microcatheter [1] - This designation marks the first FDA breakthrough for a product treating intracranial atherosclerotic stenosis globally and the first for a domestic neuro-interventional device [1] - The COMETIU stent system is designed for patients with intracranial atherosclerotic stenosis ≥70% who have failed drug therapy, while the COMEX microcatheter is used for balloon dilation and improving ischemic brain tissue [1] - The recognition is expected to enhance the company's international product layout and brand recognition, although it currently has no impact on the company's performance [1]